Sensitivity and Specificity of CTPA for Pulmonary Embolism
CTPA is highly sensitive and specific for diagnosing pulmonary embolism, with sensitivity of 83% and specificity of 96% according to the most recent ACR guidelines, making it the first-line diagnostic imaging test for suspected PE. 1
Diagnostic Performance Characteristics
Overall Accuracy
- Modern multidetector CTPA demonstrates sensitivities of 99-100% and specificities of 100% for detecting thromboembolic disease at the segmental level, representing the highest quality evidence for central and segmental PE detection 2
- The ACR Appropriateness Criteria (2022) confirms CTPA is highly sensitive and specific, with the false-negative rate being very low 3
- When combined with clinical assessment and D-dimer testing, CTPA achieves very high positive and negative predictive values 4
Performance by Vessel Size
- CTPA reliably detects emboli down to 2-3 mm in subsegmental arteries, though accuracy decreases at the subsegmental level compared to more proximal vessels 4, 2
- Interobserver agreement is good even with relatively inexperienced assessors, particularly to the segmental level 5
- The main limitation compared to conventional angiography is reduced sensitivity for isolated subsegmental clot, though 94-96% of patients with subsegmental PE also have more proximal clot that can be reliably identified 5
Clinical Outcome Data (Most Important)
Safety of Negative CTPA
- The negative predictive value is 96% for low clinical probability and 89% for intermediate probability, allowing clinicians to safely withhold anticoagulation after a negative study 1
- Outcome studies demonstrate no adverse outcomes in patients with negative CTPA who were not subsequently treated 4
- Three recent studies found subsequent PE in only 9 of 854 patients (1.1%) by 3 months after negative CTPA 5
Positive Predictive Value
- A positive CTPA combined with high or intermediate clinical suspicion has high positive predictive value 4
- The combination of CTPA with clinical probability assessment significantly enhances diagnostic accuracy 4
Technical Factors Affecting Accuracy
Optimal Performance Requirements
- Slice thickness of 2-3 mm with reconstruction index of 2 mm is required for adequate segmental and subsegmental vessel analysis 2
- Meticulous attention to technique, particularly contrast timing, is necessary to achieve published accuracy rates 5
- A small proportion of examinations (up to 25% in some studies) may be technically inadequate 3
- Multiplanar reformations and 3D renderings are essential components distinguishing CTPA from standard CT chest protocols 1, 2
Comparison to Historical Standards
Versus Conventional Pulmonary Angiography
- The overall accuracy of catheter pulmonary angiography is likely inferior to CTPA due to technical factors including patient movement, vessel overlap, and inter/intraobserver variability 4
- Even with subsegmental clot, conventional angiography shows interobserver disagreement in up to one-third of cases 5
- Conventional angiography has estimated morbidity of 3.5-6% and mortality of 0.2-0.5% 3
Versus V/Q Scanning
- CTPA is clearly superior in specificity to V/Q scanning 5
- CTPA has fewer nondiagnostic studies than V/Q scans 4
- Modern multidetector CTPA has achieved equivalent sensitivity of 99-100% to V/Q scanning for chronic thromboembolic disease 2
Important Clinical Caveats
Subsegmental PE Controversy
- The clinical significance and need for treatment of isolated subsegmental PE remains controversial, as these very small clots may be of indeterminate clinical significance 4, 1
- Only 1% of high-probability V/Q scans correspond to isolated subsegmental PE, compared with 15% of positive CTPA scans 4
Limitations and Contraindications
- CTPA requires intravenous iodinated contrast, limiting use in patients with severe renal dysfunction or contrast allergies 1
- Radiation dose is 3-10 mSv, which may be a consideration especially in young women due to breast tissue exposure 1
- Technical adequacy requires patient cooperation for breath-holding and appropriate contrast bolus timing 5, 2